BRIEF published on 02/25/2026 at 09:05, 1 month 12 days ago Hoenle AG Reports Positive Q1 Results Amid Mixed Segment Performance Revenue Market Expansion Q1 Results Hoenle AG Disinfection Growth
PRESS RELEASE published on 02/25/2026 at 09:00, 1 month 12 days ago Original-Research: Hoenle AG (von NuWays AG): BUY Hoenle AG's Q1 results for FY 25/26: Revenue flat at €21.5m, strong Disinfection growth, Curing weak. EBITDA ahead at €0.5m. Expecting growth in revenue & EBITDA for FY 25/26 EBITDA Q1 Results Disinfection Hoenle AG FY 25/26
BRIEF published on 02/02/2026 at 09:05, 2 months 7 days ago Hoenle AG Forecasts Growth Amid Challenging Market Conditions Revenue Growth Market Outlook EBITDA Improvement Hoenle AG FY 24/25 Earnings
PRESS RELEASE published on 02/02/2026 at 09:00, 2 months 7 days ago Original-Research: Hoenle AG (von NuWays AG): BUY Hoenle AG's research update by NuWays AG reveals FY 24/25 results and FY 25/26 expectations, highlighting revenue and EBITDA trends across Disinfection, Adhesives, and Curing segments NuWays AG Research Update Hoenle AG FY 24/25 Results FY 25/26 Expectations
BRIEF published on 12/10/2025 at 09:05, 3 months 30 days ago Hoenle AG: Strategic Advances Amid Challenging Market Conditions Growth Strategy Financial Forecast Market Leadership UV Technology Hoenle AG
PRESS RELEASE published on 12/10/2025 at 09:00, 3 months 30 days ago Original-Research: Hoenle AG (von NuWays AG): BUY NuWays AG updates research on Hoenle AG, recommending BUY with a target price of EUR 15.00. Hoenle leads in UV curing devices, offering solutions in adhesives, curing, and disinfection, focusing on niche markets Investment NuWays AG Research Hoenle AG UV Curing
BRIEF published on 12/03/2025 at 09:05, 4 months 6 days ago Hoenle AG Poised for Growth Amid Strategic Shifts EBITDA Margin Sales Growth Strategic Transformation Hoenle AG Disinfection Business
PRESS RELEASE published on 12/03/2025 at 09:00, 4 months 6 days ago Original-Research: Hoenle AG (von NuWays AG): BUY Update on Hoenle AG by NuWays AG highlighting FY24/25 figures meeting guidance, FY25/26 growth expectations, strong EBITDA margin, and long-term prospects. Company poised for strategic transformation EBITDA Margin NuWays AG FY24/25 Hoenle AG FY25/26
Published on 04/09/2026 at 16:00, 46 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 2 hours 6 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 2 hours 46 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 3 hours 16 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 3 hours 16 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 15:40, 1 hour 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 1 hour 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 15:39, 1 hour 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 04/09/2026 at 15:57, 48 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 9 hours 46 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 22 hours 44 minutes ago Publication of the 2025 Universal Registration Document
Published on 04/08/2026 at 17:45, 23 hours 1 minute ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 04/08/2026 at 12:58, 1 day 3 hours ago EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH
